entity

EPA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about EPA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

30Hypotheses

0Analyses

5Outgoing

0Incoming

9Experiments

0Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

European Prevention of Alzheimer's Dementia (EPAD)

institution · 1533 words

→

EPAS1 Gene

gene · 1410 words

→

Outgoing (5)

Target	Relation	Type	Str
Inflammation	protects_against	process	0.90
Kennedy Cycle	involved_in	pathway	0.85
Triglyceride Levels	downregulates	phenotype	0.85
Major Depression	treats	disease	0.80
Neuroprotection	mediates	process	0.80

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43	0.820	neurodegeneration	What is the therapeutic window between i
Hypothesis 3: HepaCAM-Containing Extracellular Vesicles	0.762	neurodegeneration	View
VHH-Fc Fusion Constructs with Separate BBB-Targeting Moiety	0.750	neurodegeneration	Blood-brain barrier antibody transport m
Inhibiting Heparan Sulfate Proteoglycan Receptor-Mediated Ne	0.740	neuroscience	Trans-synaptic tau spreading and propaga
plasma LPS-binding protein separates causal from compensator	0.738	neurodegeneration	How does gut microbiome dysbiosis contri

ATAC-seq accessibility separates causal from compensatory st	0.738	neurodegeneration	Are DNA methylation changes in neurodege
plasma GFAP separates causal from compensatory states in: Bl	0.738	neurodegeneration	Blood-brain barrier permeability changes
K48/K63 ubiquitin chain balance separates causal from compen	0.738	neurodegeneration	How do ALS-linked UBQLN2 mutations affec
ATAC-seq accessibility separates causal from compensatory st	0.738	neurodegeneration	Are age-related DNA methylation changes
Phase-Separated Organelle Targeting	0.729	neurodegeneration	Microglia-astrocyte crosstalk amplificat
Stress Granule Phase Separation Modulators	0.720	neurodegeneration	RNA binding protein dysregulation across
TRIM21 as a 'Phase Separation Thermostat' via Catalytic Reve	0.700	neurodegeneration	How does TRIM21-mediated K63 ubiquitinat
Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mi	0.681	neurodegeneration	CRISPR-based therapeutic approaches for
Oligodendrocyte DNA Repair Enhancement Therapy	0.665	neurodegeneration	Cell type vulnerability in Alzheimer's D
Time-Dependent BBB Repair Strategy	0.656	-	Blood-brain barrier tight junction disru
p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle	0.649	neurodegeneration	How do different organelle-specific auto
Small Molecule Modulation of Phase Separation	0.640	neurodegeneration	What determines the specificity of RNA-p
Hierarchical Phase Separation with Scaffold Cores	0.630	neurodegeneration	What determines the specificity of RNA-p
Programmable Neuronal Circuit Repair via Epigenetic CRISPR	0.630	neurodegeneration	CRISPR-based therapeutic approaches for
Combine Anti-AQP4 Autoimmunity Control with Astrocyte-Endfoo	0.630	neurodegeneration	How can AQP4 be effectively targeted the
ALS-Associated G3BP1 Mutations Shift Phase Separation Equili	0.610	neurodegeneration	How do disease-associated mutations in G
Liquid-Liquid Phase Separation Modifier Therapy	0.551	neurodegeneration	Protein aggregation cross-seeding across
Oligodendrocyte DNA Repair Enhancement	0.550	neurodegeneration	Cell type vulnerability in Alzheimers Di
Systemic IL-6–STAT3–Hepatic C3 Axis and BBB-Mediated Complem	0.540	neuroinflammation	How does sevoflurane-induced NF-κB activ
Lysosomal Membrane Repair Enhancement	0.538	neurodegeneration	Autophagy-lysosome pathway convergence a
PI3P Generation at Damaged Lysosomes Promotes Membrane Repai	0.530	neurodegeneration	How does controlled lysosomal membrane p
Liquid-Liquid Phase Separation (LLPS) Saturation Partitionin	0.461	neurodegeneration	What determines the spatial organization
DNA Damage Repair Dysfunction Creating TDP-43 Pathology Feed	0.430	neurodegeneration	How does APOE4 mechanistically increase
Heparan sulfate proteoglycan binding selectivity determines	0.000	Alzheimer's disease, Parkinson's disease, ALS	What determines the selectivity and effi
TREM2-Mediated Microglial Regulation of Oligodendrocyte Prec	0.000	connectomics	Human connectome alterations in Alzheime

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (9)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
G3BP1-mediated stress granule assembly via liquid-liquid phase separat	exploratory		0.900	0.00	eukaryotic cells	proposed	N/A
G3BP1 intrinsically disordered region analysis and phosphorylation eff	exploratory		0.850	0.00	in vitro protein analysis syst	proposed	N/A
G3BP1-binding factor cooperativity in stress granule network regulatio	exploratory		0.800	0.00	cell culture systems with prot	proposed	N/A
Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FTD	validation	ALS	0.400	0.50	human	proposed	$2,730,000
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Pre-Symptomatic Detection and Intervention Timing in Genetic Prion Dis	validation	ALS	0.400	0.50	human	proposed	$2,280,000
Stress Granule Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Experiment Validation: In vitro ThT Assay	validation	Alzheimer's Disease	0.400	0.50	cell_line	proposed	$160,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3B [PMID:36692217]	Yang C, Wang Z, Kang Y, Yi Q, Wang T, Ba	Autophagy	2023	3
G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Gran [PMID:32302571]	Yang P, Mathieu C, Kolaitis RM, Zhang P,	Cell	2020	3
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic t [PMID:32048886]	Yao RQ, Ren C, Xia ZF, Yao YM	Autophagy	2021	2
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745]	Yu CH, Davidson S, Harapas CR, Hilton JB	Cell	2020	2
Hypoxia-driven phase separation of the PABP1/eIF4B complex forms stress granules [PMID:41780839]	Lin Z, Gao Y, Zhang Q, Yang S, Chen Y, D	Cancer Lett	2026	1
Membrane Atg8ylation, stress granule formation, and MTOR regulation during lysos [PMID:36394332]	Jia J, Wang F, Bhujabal Z, Peters R, Mud	Autophagy	2023	1
Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal [PMID:41498748]	Unknown	The Journal of cell biology	2026	0
Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal [PMID:41498748]	Byrd, Marmorale, Marcinowski, Dykstra, A	The Journal of cell biology	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Translational neurodegeneratio	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Transl Neurodegener	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Front Pharmacol	2026	0
Stress granules at the crossroads of retroviral replication and antiviral immuni [PMID:41931190]	Akbarin MM, Farjami Z, Álvarez HR	Mol Biol Rep	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Frontiers in pharmacology	2026	0
Proteasome inhibition by VR23 enhances autophagic clearance of FUSP525L-mediated [PMID:41508039]	Kim SH, So JH, Kim YH, Kim HS, Park NY,	Molecular brain	2026	0
AAV2-driven endothelin induces chronic reduced retinal blood flow/retinal gangli [PMID:40345829]	Shi, Sato, Takahashi, Ohno-Ohishi, Muray	Life science alliance	2025	0
The UNC5C T835M mutation associated with Alzheimer's disease leads to neurodegen [PMID:40468412]	Karunakaran DKP, Ley M, Guo J, Khatri A,	Molecular neurodegeneration	2025	0
AAV2-driven endothelin induces chronic reduced retinal blood flow/retinal gangli [PMID:40345829]	Unknown	Life science alliance	2025	0
The UNC5C T835M mutation associated with Alzheimer's disease leads to neurodegen [PMID:40468412]	Karunakaran DKP, Ley M, Guo J, Khatri A,	Molecular neurodegeneration	2025	0
Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy [PMID:38056575]	Wu S, Zhou Y, Liang J	Free Radic Biol Med	2024	0
Ripks and Neuroinflammation. [PMID:38349514]	Xu Y, Lin F, Liao G, Sun J, Chen W, Zhan	Molecular neurobiology	2024	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning EPA in their description or question text

ATAC-seq accessibility separates causal from compensatory states in: Are DNA met

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

plasma GFAP separates causal from compensatory states in: Blood-brain barrier pe

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on plasma GFAP can distinguish harmful mechanisms from protective adaptation. Th

K48/K63 ubiquitin chain balance separates causal from compensatory states in: Ho

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on K48/K63 ubiquitin chain balance can distinguish harmful mechanisms from prote

ATAC-seq accessibility separates causal from compensatory states in: Are age-rel

Score: 0.738 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

Phase-Separated Organelle Targeting

Score: 0.729 · neurodegeneration · 2026-04-02

## Molecular Mechanism and Rationale Stress granules (SGs) are membraneless, phase-separated ribonucleoprotein organell

Stress Granule Phase Separation Modulators

Score: 0.720 · neurodegeneration · 2026-04-02

## Mechanistic Overview Stress Granule Phase Separation Modulators starts from the claim that modulating G3BP1 within th

TRIM21 as a 'Phase Separation Thermostat' via Catalytic Reversibility

Score: 0.700 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The TRIM21-mediated regulation of stress granule (SG) formation represents a soph

Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modula

Score: 0.681 · neurodegeneration · 2026-04-04

## Mechanistic Overview Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modulation starts from

Oligodendrocyte DNA Repair Enhancement Therapy

Score: 0.665 · neurodegeneration · 2026-04-04

## Mechanistic Overview Oligodendrocyte DNA Repair Enhancement Therapy starts from the claim that modulating PARP1 and X

Time-Dependent BBB Repair Strategy

Score: 0.656 · unknown disease · 2026-04-16

## Mechanistic Overview Time-Dependent BBB Repair Strategy starts from the claim that modulating MULTIPLE within the dis

p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinat

Score: 0.649 · neurodegeneration · 2026-04-21

## Mechanistic Overview p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle Cargo for Coordinated Autophagy sta

Small Molecule Modulation of Phase Separation

Score: 0.640 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The therapeutic strategy centers on modulating liquid-liquid phase separation (LL

Hierarchical Phase Separation with Scaffold Cores

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The hierarchical phase separation model proposes a sophisticated two-tier mechani

Programmable Neuronal Circuit Repair via Epigenetic CRISPR

Score: 0.630 · neurodegeneration · 2026-04-02

## Mechanistic Overview Programmable Neuronal Circuit Repair via Epigenetic CRISPR starts from the claim that modulating

Combine Anti-AQP4 Autoimmunity Control with Astrocyte-Endfoot Repair in NMOSD

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The pathophysiology of neuromyelitis optica spectrum disorder (NMOSD) centers on